{"count": 2, "results": [{"_id": "36474458", "pmid": 36474458, "title": "Metformin: new applications for an old drug.", "journal": "J Basic Clin Physiol Pharmacol", "authors": ["Naseri A", "Sanaie S", "Hamzehzadeh S", "Seyedi-Sahebari S", "Hosseini MS", "Gholipour-Khalili E", "Rezazadeh-Gavgani E", "Majidazar R", "Seraji P", "Daneshvar S", "Rezazadeh-Gavgani E"], "date": "2022-12-07T00:00:00Z", "doi": "10.1515/jbcpp-2022-0252", "meta_date_publication": "2022 Dec 7", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50257.637, "text_hl": "There is evidence of the beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Colorectal_Neoplasms @DISEASE_MESH:D015179 @@@colorectal cancer@@@, early-stage @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@, @DISEASE_Breast_Neoplasms @DISEASE_MESH:D001943 @@@breast cancer@@@, @<m>DISEASE_Urethral_Neoplasms</m> @DISEASE_MESH:D014523 @@@urothelial cancer@@@, @DISEASE_Hematologic_Neoplasms @DISEASE_MESH:D019337 @@@blood cancer@@@, @DISEASE_Melanoma @DISEASE_MESH:D008545 @@@melanoma@@@, and @DISEASE_Bone_Neoplasms @DISEASE_MESH:D001859 @@@bone cancer@@@, suggesting @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as a potent anti-@DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ agent. ", "citations": {"NLM": "Naseri A, Sanaie S, Hamzehzadeh S, Seyedi-Sahebari S, Hosseini MS, Gholipour-Khalili E, Rezazadeh-Gavgani E, Majidazar R, Seraji P, Daneshvar S, Rezazadeh-Gavgani E. Metformin: new applications for an old drug. J Basic Clin Physiol Pharmacol. 2022 Dec 7;():. PMID: 36474458", "BibTeX": "@article{36474458, title={Metformin: new applications for an old drug.}, author={Naseri A and Sanaie S and Hamzehzadeh S and Seyedi-Sahebari S and Hosseini MS and Gholipour-Khalili E and Rezazadeh-Gavgani E and Majidazar R and Seraji P and Daneshvar S and Rezazadeh-Gavgani E}, journal={J Basic Clin Physiol Pharmacol}}"}}, {"_id": "24140245", "pmid": 24140245, "title": "Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.", "journal": "Urol Oncol", "authors": ["Rieken M", "Xylinas E", "Kluth L", "Crivelli JJ", "Chrystal J", "Faison T", "Lotan Y", "Karakiewicz PI", "Sun M", "Fajkovic H", "Babjuk M", "Bachmann A", "Scherr DS", "Shariat SF"], "date": "2014-01-01T00:00:00Z", "doi": "10.1016/j.urolonc.2013.07.006", "meta_date_publication": "2014 Jan", "meta_volume": "32", "meta_issue": "1", "meta_pages": "49.e7-14", "score": 50060.53, "text_hl": "Effect of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use on oncologic outcomes of @SPECIES_9606 @@@patients@@@ treated with radical cystectomy for @<m>DISEASE_Urethral_Neoplasms</m> @DISEASE_MESH:D014523 @@@urothelial carcinoma@@@.", "citations": {"NLM": "Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Urol Oncol. 2014 Jan;32(1):49.e7-14. PMID: 24140245", "BibTeX": "@article{24140245, title={Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.}, author={Rieken M and Xylinas E and Kluth L and Crivelli JJ and Chrystal J and Faison T and Lotan Y and Karakiewicz PI and Sun M and Fajkovic H and Babjuk M and Bachmann A and Scherr DS and Shariat SF}, journal={Urol Oncol}, volume={32}, number={1}, pages={49.e7-14}}"}}]}